Health & Disease Management Overview

The Health & Disease Management Service is an ongoing research project that focuses on health and disease management initiatives within significant managed care customer segments. This research provides benchmarking profiles of manufacturer, disease management organization and PBM disease management program investment across the commercial HMO, Medicare and employer segments.  The service also includes in-depth case studies that highlight the key components of disease management program collaborations between pharmaceutical manufacturers and health plans.

Who Should Subscribe?

Health management executives, sales support, brand managers and account managers who want to successfully implement disease management programs to improve patient outcomes and promote appropriate utilization. 

Why Subscribe?

To acquire key strategic information that supports pharmaceutical companies’ disease management efforts. Research information provided will assist manufacturers in positioning DM programs that meet the needs of their customers. The service examines the manufacturer benefits of disease management program investment including:

• Increasing market share of their products upon adoption of their program, with the additional goal of increasing patient compliance through appropriate use of medication
• Enhancing the formulary position for their products and providing a competitive edge over other brands
• Improving strategic relationships, not only with managed care organizations, but also employer coalitions and Medicare Advantage plans
• Promoting physician access to disease management programs for their patients